Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H21ClN2O2S |
| Molecular Weight | 376.9 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(C=C1)S(=O)(=O)\N=C2\CCCCN2CCC3=CC=CC=C3
InChI
InChIKey=VJHXSSVOCOBVMI-VZCXRCSSSA-N
InChI=1S/C19H21ClN2O2S/c20-17-9-11-18(12-10-17)25(23,24)21-19-8-4-5-14-22(19)15-13-16-6-2-1-3-7-16/h1-3,6-7,9-12H,4-5,8,13-15H2/b21-19-
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20855776
Created by
admin on Sat Dec 16 10:26:41 GMT 2023 , Edited by admin on Sat Dec 16 10:26:41 GMT 2023
|
PRIMARY | |||
|
4-CHLORO-N-(1-(2-PHENYLETHYL)PIPERIDIN-2-YLIDENE)BENZENESULFONAMIDE
Created by
admin on Sat Dec 16 10:26:41 GMT 2023 , Edited by admin on Sat Dec 16 10:26:41 GMT 2023
|
PRIMARY | |||
|
93100-99-3
Created by
admin on Sat Dec 16 10:26:41 GMT 2023 , Edited by admin on Sat Dec 16 10:26:41 GMT 2023
|
PRIMARY | |||
|
14898
Created by
admin on Sat Dec 16 10:26:41 GMT 2023 , Edited by admin on Sat Dec 16 10:26:41 GMT 2023
|
PRIMARY | |||
|
71463939
Created by
admin on Sat Dec 16 10:26:41 GMT 2023 , Edited by admin on Sat Dec 16 10:26:41 GMT 2023
|
PRIMARY | |||
|
AW2Z8RD4XK
Created by
admin on Sat Dec 16 10:26:41 GMT 2023 , Edited by admin on Sat Dec 16 10:26:41 GMT 2023
|
PRIMARY | |||
|
W-15
Created by
admin on Sat Dec 16 10:26:41 GMT 2023 , Edited by admin on Sat Dec 16 10:26:41 GMT 2023
|
PRIMARY | Data on analgesic activity/potency (from the patent):Doses needed for effective inhibition of phenylquinone writhing (i.e. dose needed to produce analgetic effect in rats) - W-15 = 0.007 mg/kg (~5.5x morphine)morphine sulphate = 0.038 mg/kgaspirin = 50 mg/kgdextropropoxyphene = 56 mg/kg (1/1500 the potency of morphine) |
ACTIVE MOIETY
